http://profyeclm725c2qydxymtb7fs2v2cmcuz5ic5pu2xir2gw2u7ytnntid.onion/blog-headlines.html
Throughout these posts, I’ve discussed how Salvinorin A itself is not ideal for therapy due to its short duration of action and the intense psychedelic effects it induces. As such, scientists are currently trying to create compounds that are based on Salvinorin A, but with additional desirable qualities, such as a longer duration of action and affinity for other receptors..